In Europe, dying from a heart attack still depends largely on which country you live in. According to the OECD, preventable hospital admissions for heart failure varied from one to more than four between European Union member states in 2023, around an average of 232 per 100,000 inhabitants. The organization estimates that aligning the worst-performing countries with the best would save 45 billion euros per year, or 16% of Europe’s 2021 cardiovascular spending. Screening must be completed by rapid diagnosis, treatment, and follow-up to improve outcomes.
The Essentials
- In 2023, preventable heart failure hospitalizations varied from one to more than four depending on the EU country, around an average of 232 per 100,000 inhabitants (OECD).
- Bringing cardiovascular admissions down to Canada’s reference rate is estimated to reduce EU hospital spending by approximately 45 billion euros per year.
- The gaps are consistent with differences in access, continuity, and organization of primary care.
- The OECD reports an estimate of cardiovascular disease prevalence potentially rising by up to 90% in Europe between 2025 and 2050: without investment in community-based medicine, this one-to-four gap risks widening.
- Models exist—multidisciplinary teams, results-based payment, documented follow-up—but their rollout remains uneven.
One to Four: What the European Average Hides
The average of 232 preventable admissions per 100,000 inhabitants masks a far more stark reality. In the best-performing countries—Nordic countries and the Netherlands regularly rank high in OECD assessments of primary care quality—this rate falls well below average. In the worst-performing countries, mainly in the eastern and southeastern part of the continent, it exceeds the average by more than double. For a heart failure patient, this gap translates into repeated hospitalizations, years of diminished life quality, and mounting costs.
These admissions are considered largely preventable through high-quality primary care, though they can also reflect clinical severity and access to hospital care. A patient who sees a general practitioner regularly, whose treatments are adjusted before symptoms spiral, who knows who to contact when a warning sign appears: this patient doesn’t end up in the emergency room. The one without this safety net returns two to three times a year.
The OECD presents continuity, coordination, screening with follow-up, and adequate hospital capacity as complementary improvement levers.
Screening Without Follow-Up Doesn’t Save Lives
Cardiovascular screening has existed in several European countries for years. Campaigns measuring cholesterol, blood pressure, and diabetes have been implemented. In several countries, early detection of risk factors has reached levels previous generations would not have imagined. Yet preventable admissions have generally declined, but gaps between countries remain significant.
The explanation lies in a missing link in the chain. Detecting high cardiovascular risk in a 58-year-old patient is not enough. An accessible health professional must follow up with this patient in the weeks that follow, adjust treatment, verify compliance, call them if they miss an appointment. In systems where this chain works, care continuity, coordination, and incentives for quality are associated with better cardiovascular management. Where the chain breaks after the initial consultation, what remains is data in a registry.
This dynamic is not unique to cardiology, but it is particularly visible there because heart failure is managed over time. It is a chronic disease that tolerates few interruptions in follow-up. Each preventable decompensation that ends up in the emergency room represents a month of expensive hospital treatment, and often an acceleration of the patient’s functional decline. The epidemiological surveillance through wastewater illustrates the same limitation: detecting is only valuable if a decision follows.
The Netherlands and Nordic Countries Have Solved a Problem Others Still Don’t Know About
Several European systems have patiently built a primary care architecture that absorbs the follow-up of chronic diseases before they overflow into hospitals. The Netherlands has developed stable multidisciplinary teams—general practitioner, advanced practice nurse, dietitian—anchored in neighborhood health centers. Sweden and Denmark have invested in shared information systems that allow general practitioners to see laboratory results, emergency visits, and hospital prescriptions in real time. In Finland, clear protocols define who does what among general practitioners, cardiologists, and specialized nurses.
What unites these approaches: a stable relationship between a professional and a patient over time, a medical record that circulates without interruption among care providers, and payment that rewards not only services provided but also results, particularly the reduction of hospitalizations.
The British National Health Service model, despite its well-documented budget tensions, has maintained a tradition of list-based medicine where each patient is registered with a practice, producing relational continuity difficult to replicate in more fragmented systems. OECD data show that the United Kingdom, outside the EU but comparable, displays rates of preventable admissions lower than several Central European countries.
Conversely, in fragmented systems where patients must navigate alone among actors who don’t communicate with each other, the hospital often becomes the first resort. The heart failure patient without follow-up calls 112 when they can no longer breathe. Emergency hospitalization costs significantly more than a scheduled follow-up appointment.
The 45 Billion Euros as a Marker of Political Priorities
The figure put forward by the OECD, 45 billion euros in potential savings, corresponds to the estimated reduction in EU hospital spending if all cardiovascular admissions reached Canada’s reference rate. This is better-placed care in the chain, for the direct benefit of patients.
The reasoning has a direct political implication. Investing in stable primary care teams, in interoperable information systems, in training advanced practice nurses capable of managing cardiovascular follow-up between medical consultations: all of this costs money in the short term. But preventable admissions constitute an indicator of quality and access to primary care, capable of illuminating potential savings, but not a direct measure of return on investment. Systems that made this choice twenty or thirty years ago are reaping the benefits in their admission statistics today.
Discussions about public finances in Europe, and the resulting trade-offs for health budgets, tend to concentrate attention on the immediate costs of personnel and infrastructure spending. The lack of continuity can contribute to fragmentation of care.
Between 2025 and 2050, the Cardiovascular Burden Will Increase
A study by Chong et al. projects a global increase of 90% in gross cardiovascular prevalence between 2025 and 2050; the OECD cites it in its report. The projection is explicitly linked to demographic aging, while obesity, inactivity, and diabetes constitute additional risk factors. The cardiovascular burden will increase; European demography is already tracing its direction.
Thus, the current one-to-four gap between countries on preventable admissions is not a temporary anomaly. Under two distinct scenarios, it traces very different trajectories for the decades to come.
In the first, countries invest in primary care capable of absorbing mass cardiovascular follow-up. Community-based teams become the pivot between screening and sustainable care. High-risk patients benefit from documented follow-up within twelve months of identification. Preventable admissions decline, and the savings projected by the OECD begin to materialize. Signals of this scenario already exist: Spain is experimenting with multidisciplinary teams dedicated to chronic disease management in several autonomous communities; Belgium has launched integrated care networks that condition part of funding on demonstrating post-screening follow-up.
In the second, health policies continue to fund screening campaigns without guaranteeing downstream follow-up capacity. The gap between countries persists, and under demographic pressure, some less-prepared systems could face a large volume of preventable admissions. Screening, in this case, serves only to document a risk that no one has the means to treat sustainably.
What would make it possible to distinguish the two trajectories in the coming years: the evolution of the rate of preventable admissions in countries currently above the OECD average, and the share of patients screened at high risk who benefit from documented follow-up within twelve months. These two indicators are measurable. They are not yet measured systematically.
Linking Screening to Follow-Up: A Governance Problem as Much as a Medical One
The main obstacle to the virtuous scenario is not medical. The tools exist: cardiovascular follow-up protocols in general medicine are well-known, effective medications are available and generic, advanced nursing training programs are developing in several countries. Governance is a significant obstacle among several systemic constraints.
Conditioning public health financing on demonstrating follow-up capacity, rather than solely on participation rates in campaigns, is a concrete lever. Compensating community-based teams for reducing preventable admissions rather than for the number of services produced is another. Building an information system that traces a patient from screening to care, without interruption, in environments where medical software doesn’t communicate with each other, is part of the same imperative. These directions are political in the strictest sense: they require choices about the structure of incentives, allocation of resources, and public investment priorities.
The European Union has levers available. Cohesion funds and public health financing could be conditioned not on process indicators—how many campaigns launched, how many people screened—but on outcome indicators: how many patients detected at high risk benefited from documented follow-up within the year. This type of conditionality already exists in other areas of European public policy. Applying it to cardiovascular health is not a rupture: it’s a logical extension of a proven method. The question of how to direct public spending toward measurable results runs through other European policies with the same tensions.
The issue goes beyond cardiology. Chronic diseases—diabetes, kidney failure, chronic obstructive lung disease—share exactly the same logic: stable community-based follow-up reduces decompensations, emergencies, costly hospitalizations. Cardiology is simply the terrain where the OECD has produced the most precise data, and where the gap between countries is most documented.
Immediate Action Margins for Lagging Countries
Countries displaying the highest rates of preventable admissions are not starting from zero. Several have undertaken general medicine reforms that are beginning to produce measurable effects. Hungary has strengthened its district health centers with nurses specialized in chronic disease follow-up. Poland is experimenting with coordination networks between hospital cardiologists and general practitioners, with an automatic reminder system for patients who miss follow-up appointments.
These initiatives remain fragmented and their scale-up is slow. But they show that the gap documented by the OECD is not a geographic or cultural inevitability. The gaps are consistent with a role for primary care organization and care pathway integration, among other factors such as hospital access and data comparability. Provided that results on preventable admissions become a real criterion for evaluating health systems, and not just a statistic in an international report.
Several countries will probably wait for the next wave of cardiovascular decompensations linked to aging before investing in what the best European systems have patiently built over the past thirty years.



